1) Chronic kidney disease is defined as either kidney damage or decreased glomerular filtration rate (GFR) below 60 mL/min/1.73m2 for at least three months. 2) Fluid therapy for patients with chronic kidney disease undergoing surgery aims to prevent hypo- and hypervolemia as well as electrolyte abnormalities while avoiding exacerbating kidney injury or progression to end-stage renal disease. 3) Goal-directed fluid therapy utilizing dynamic parameters like stroke volume variation is recommended over liberal or restrictive regimens, with choice of isotonic crystalloid like Plasmalyte over normal saline given risks of hyperchloremia with the latter.